Document Detail

Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.
MedLine Citation:
PMID:  23541043     Owner:  NLM     Status:  MEDLINE    
L-DOPA is currently one of the best medications for Parkinson's disease. It was assumed for several years that its benefits and side effects were related to the enhancement of dopamine release in the dopamine-depleted striatum. The use of intracerebral microdialysis combined with a pharmacological approach has led to the discovery that serotonergic neurons are responsible for dopamine release induced by L-DOPA. The subsequent use of multisite microdialysis has further revealed that L-DOPA-stimulated dopamine release is widespread and related to the serotonergic innervation. The present Review emphasizes the functional impact of extrastriatal release of dopamine induced by L-DOPA in both the therapeutic and side effects of L-DOPA.
S Navailles; M Lagière; A Contini; P De Deurwaerdère
Related Documents :
16930223 - Smoke exposure and ethanol ingestion modulate intrapulmonary polymorphonuclear leukocyt...
25028133 - Infrared led light therapy influences the expression of fibronectin and tenascin in ski...
10780603 - Effects of timing of diatrizoate (water-soluble contrast medium) administration on panc...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2013-04-15
Journal Detail:
Title:  ACS chemical neuroscience     Volume:  4     ISSN:  1948-7193     ISO Abbreviation:  ACS Chem Neurosci     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-07-18     Completed Date:  2013-10-22     Revised Date:  2014-05-16    
Medline Journal Info:
Nlm Unique ID:  101525337     Medline TA:  ACS Chem Neurosci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  680-92     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiparkinson Agents / pharmacology*
Brain / drug effects*
Disease Models, Animal
Dopamine / secretion
Dopaminergic Neurons / drug effects*,  secretion
Dyskinesia, Drug-Induced
Levodopa / pharmacology*
Neostriatum / drug effects
Parkinson Disease*
Serotonergic Neurons / drug effects*,  secretion
Serotonin / secretion
Reg. No./Substance:
0/Antiparkinson Agents; 333DO1RDJY/Serotonin; 46627O600J/Levodopa; VTD58H1Z2X/Dopamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ocular Graft-versus-Host Disease: A Review.
Next Document:  Experimental testing of quantum mechanical predictions of mutagenicity: aminopyrazoles.